Please check your internet connection and try again.
## Diadzein, Genistein, Palmitoylethanolamide
### Overview
This combination product contains isoflavones (daidzein and genistein) derived from soybeans and palmitoylethanolamide (PEA), an endogenous fatty acid amide. These compounds are often marketed as dietary supplements.
### Primary Indications
There are no FDA-approved indications for this combination product. It is typically used for purported benefits related to inflammation, pain, and menopausal symptoms, though clinical evidence is limited and inconsistent for these uses.
### Adult Dosing
Dosing varies widely by product formulation and intended use. Common dosages found in over-the-counter products range from:
* **Daidzein:** 20-60 mg daily
* **Genistein:** 20-60 mg daily
* **Palmitoylethanolamide (PEA):** 300-1200 mg daily, often divided into multiple doses.
Specific dosing recommendations are not established and depend on the product manufacturer.
### Pediatric Dosing
There is no established pediatric dosing for this combination product. Safety and efficacy have not been evaluated in children.
### Dose Adjustments
No specific dose adjustments are established for renal or hepatic impairment.
### Contraindications
* Hypersensitivity to any component of the product.
* Pregnancy and breastfeeding (due to lack of safety data and potential hormonal effects of isoflavones).
* Individuals with hormone-sensitive cancers (e.g., breast, ovarian, uterine cancer) should exercise caution due to the phytoestrogenic activity of daidzein and genistein.
### Adverse Effects
Adverse effects are generally mild and uncommon. Potential effects include:
* Gastrointestinal upset (nausea, abdominal discomfort)
* Headache
* Allergic reactions
Due to the phytoestrogenic nature of daidzein and genistein, potential hormonal effects such as menstrual irregularities or breast tenderness are possible, particularly at higher doses.
### Key Drug Interactions
* **Hormone Replacement Therapy (HRT):** Potential for additive estrogenic effects.
* **Tamoxifen:** Phytoestrogens may compete for binding sites, potentially reducing efficacy.
* **Thyroid medications:** Soy isoflavones may interfere with thyroid hormone absorption or function. Separate administration by at least 4 hours.
* **Anticoagulants/Antiplatelets:** Caution is advised as PEA may have mild antiplatelet effects.
### Monitoring
* Monitor for signs of gastrointestinal upset or allergic reactions.
* Patients with hormone-sensitive conditions should be monitored for any concerning changes.
* Monitor thyroid function if co-administered with thyroid medications.
### Clinical Pearls
* This is primarily a dietary supplement, not an FDA-approved medication.
* Efficacy for most claimed indications is not well-established by rigorous clinical trials.
* The specific ratio and bioavailabilty of the components can vary significantly between products.
* Patients should be advised to discuss the use of this product with their healthcare provider, especially if they have underlying medical conditions or are taking other medications.
***
**Disclaimer:** This information is intended for healthcare professionals. It is essential to consult the most current prescribing information and relevant literature for comprehensive details before making any clinical decisions. Dosing and recommendations may vary based on product specificities and local protocols.
